Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2020-11-15
2021-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Data were recorded including age, gender, duration of anesthesia, duration of surgery, postoperative analgesia consumption, complications such as respiratory distress due to hemidiaphragmatic paralysis and complications such as hematoma and nerve damage due to block intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Postoperative Analgesic Efficacy of SPSIPB and ISBPB
NCT06626191
Comparison of Postoperative Analgesic Efficacy of SPSIPB and Combination of IBPB and SCPB
NCT06660875
Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery
NCT06866054
Superior Trunk Block Applied for Upper Arm Surgery
NCT05474014
Comparison of Interscalene and Pericapsular Nerve Group (PENG) Block in Shoulder Surgery
NCT04718090
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GROUP I
Interscalene block (group I)15 ml of 0.5% bupivacaine was applied with a single injection to 12 of 18 patients,
perineural injection
perineural injection of local anesthestetic for postoperative pain management
GROUP II
7.5 ml of interscalene and 7.5 ml of suprascapular block (GROUP II) were applied to 6 patients with posterior approach.
perineural injection
perineural injection of local anesthestetic for postoperative pain management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
perineural injection
perineural injection of local anesthestetic for postoperative pain management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eskisehir Osmangazi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ferda YAMAN
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ferda YAMAN, Assoc prof
Role: STUDY_DIRECTOR
University of Eskişehir Osmangazi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ferda YAMAN
Eskişehir, Odunpazarı, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EskisehirUO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.